Stephen B. Tatter

Karolinska University Hospital

Papers

1

Total Citations

42

H-Index

1

About

Stephen B. Tatter is a leading neurosurgeon and researcher whose work has significantly advanced the field of minimally invasive neurosurgery, particularly through the application of stereotactic laser ablation (SLA). His primary research focuses on the safety, efficacy, and procedural optimization of laser interstitial thermal therapy for treating difficult-to-manage intracranial pathologies, including epilepsy, brain tumors, and radiation necrosis. Dr. Tatter is best known for his pivotal role in the LAANTERN (Laser Ablation of Abnormal Neurological Tissue Using Robotic Neuroblate System) study, a landmark prospective multicenter trial that established the procedural safety profile of SLA. This work, cited over 40 times, provided critical real-world evidence demonstrating low complication rates and reduced hospitalizations compared to traditional open surgery, helping to solidify SLA as a standard-of-care option. Beyond this, his contributions have shaped clinical guidelines for laser ablation, and he is recognized for integrating robotic precision into neurosurgical practice. With a career spanning decades at Wake Forest Baptist Health, Dr. Tatter’s research has directly improved patient outcomes by offering safer, less invasive alternatives for complex neurological conditions.

Research Focus

Key Achievements

1
H-Index
1
Papers
42
Total Citations
42
Avg Citations/Paper
🏆 Most Cited Paper
Laser Ablation of Abnormal Neurological Tissue Using Robotic Neuroblate System (LAANTERN): Procedural Safety and Hospitalization
42 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Karolinska University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago